Product Description
Bdparib 200mg Tablet is an anti-cancer agent containing the active constituent rucaparib. It is used for the maintenance treatment of patients with ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. It is used after cancer has responded to previous chemotherapy treatments. It can also be used to treat if your cancer has come back after the chemotherapy and you have an abnormality of the BRCA gene. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner.Bdparib 200mg Tablet is not recommended for adolescents and children under the age of 18. Use effective birth control during the treatment and for at least 6 months after the last dose. Limit your exposure to sunlight as you may get sunburn easily during the treatment. Use sunscreen products with a sun protection factor of 50 or higher.Storage: Store Below 30 Degree CNote: Reference price displayed herewith, kindly send inquiry with require quantity for best offers.
Rucaparib Tablets 200 mg is sold interntionally under the brand name as Rubraca (Clovis Oncology). It is also availble under the brands name as Nuparp (by Zydus Cadila), Rucaza (by Intas), Bdparib (by BDR Pharmaceuticals), Lucaparib (by Lupin and Bioc Pharmaceuticals), and Ruparib (by Emcure).
FAQs of Rucaparib Tablets 200mg:
Q: What is the indication for Rucaparib Tablets 200mg?
A: Rucaparib Tablets 200mg are indicated for cancer treatment.
Q: What is the recommended storage condition for Rucaparib Tablets 200mg?
A: Rucaparib Tablets 200mg should be stored in a cool and dry place.
Q: What is the shelf life of Rucaparib Tablets 200mg?
A: The shelf life of Rucaparib Tablets 200mg is 12 months.
Q: What is the salt composition of Rucaparib Tablets 200mg?
A: The salt composition of Rucaparib Tablets 200mg is Rucaparib.
Q: What is the country of origin for Rucaparib Tablets 200mg?
A: Rucaparib Tablets 200mg originate from India.